The European Medicines Agency (EMA) remains “firmly convinced” of the benefits of AstraZeneca’s coronavirus vaccine despite several countries suspending its use over blood clot fears, the head of the regulator said on Tuesday.
EU regulator ‘firmly convinced’ that benefits of AstraZeneca vaccine outweigh the risks
